| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-X3-C motif chemokine ligand 1 | 0.478 | 0.808 | 0.61 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2002 | 2007 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2007 | ||||||||
|
C-C motif chemokine receptor 6 | 0.485 | 0.808 | 5.8E-03 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2007 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2008 | ||||||||
|
complement C5 | 0.550 | 0.731 | 8.1E-24 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2008 | ||||||||
|
von Willebrand factor | 0.408 | 0.885 | 3.2E-25 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2005 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2006 | ||||||||
|
interleukin 15 | 0.422 | 0.846 | 0.71 |
|
phenotype | 0.220 | None | 1.000 | 2 | 0 | 2002 | 2003 | ||||||||
|
fibroblast growth factor 1 | 0.507 | 0.846 | 0.44 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2005 | ||||||||
|
signal peptide, CUB domain and EGF like domain containing 1 | 0.743 | 0.500 | 0.96 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
nuclear receptor coactivator 6 | 0.647 | 0.731 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
general transcription factor IIA subunit 1 | 0.805 | 0.192 | 0.99 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 2002 | 2010 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
plasminogen activator, urokinase receptor | 0.536 | 0.731 | 5.3E-03 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
signal peptide, CUB domain and EGF like domain containing 2 | 0.743 | 0.231 | 3.6E-21 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
pleiotrophin | 0.515 | 0.808 | 7.5E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
cathepsin B | 0.457 | 0.846 | 5.9E-11 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
vitronectin | 0.509 | 0.769 | 1.5E-10 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
C-X-C motif chemokine ligand 11 | 0.519 | 0.808 | 0.31 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2012 | ||||||||
|
transmembrane immune signaling adaptor TYROBP | 0.573 | 0.769 | 0.20 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
lactotransferrin | 0.543 | 0.846 | 1.3E-21 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2005 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.400 | None | 1.000 | 11 | 0 | 2003 | 2014 |